Pharm Pulmonary Exam 2 Flashcards
COPD order of therapy
LAMA
Then
LABA
Then
ICS
Stable COPD
Quick relief of symptoms
for patients already on a LAMA
SABA
Short acting beta agonist
Stable COPD
Group B
GOLD ABCD
Group B is usually hospitalized with steroids
moderate to severe symptoms
Tiotropium
Spiriva (long acting anticholinergic)
For long term maintenance of bronchospasm due to COPD. Includes chronic bronchitis and emphysema.
Reduces exacerbations of COPD
Dose: 2 puffs of one capsule (18mcg) QD
Contra
Allergy to ipratropium
Interactions:
Other anticholinergics
Adverse:
Anti-cholinergic effects, Glaucoma, dysuria, blurred vision, constipation, urinary retention
Symbicort Name
Budesonide - formoterol MDI
Advair HFA Name
Fluticasone propionate - salmeterol MDI
Advair Diskus Name
Fluticasone propionate - salmeterol DPI
Breo Ellipta Name
Fluticasone furoate - vilanterol DPI
Dulera Name
Mometasone - formoterol MDI
Fluticasone propionate - salmeterol MDI
250 mcg / 50mcg
Advair Diskus
(corticosteroid + LABA)
Dose: Asthma:
>12 y/o = 1 puff of 100/50 or 250/50 or 500/50 BID
Children: rinse mouth after use
Contra:
Primary treatment of status asthmaticus or other acute asthma or COPD
Interactions:
Caution during 2 weeks of discontinuing MAOI’s or tricyclics
Adverse:
URI
2 Combo LAMA/LABA’s
Tiotropium 2.5mcg
olodaterol 5.5mcg
(Stiolto Respimat)
Fluticasone furoate 100mcg
umeclidnium 62.5mcg
vilanterol 25mcg
(Trelegy Ellipta)
COPD exacerbation definition
Acute increase in symptoms beyond normal day to day variation that leads to a change in medication
COPD exacerbation treatment
SABA is mainstay of treatment
Short acting beta-adrenergic agonist
(albuterol, Levalbuterol)
All patients with COPD exacerbation should get steroids
ICU dose = prednisone 40-60 PO QD 5-14 days
ABX may be indicated for many patients
COPD exacerbation ABX treatment
No pseudomonas risk factors:
Used for majority of COPD exacerbations
(use pseudomonas risk factors, sputum cultures and patterns of resistance)
No pseudomonas risk factors:
1-2 g Cef IV,
or
levo 500 IV
or
moxi 400 IV
COPD exacerbation ABX treatment
Yes pseudomonas risk factors:
Used for majority of COPD exacerbations
(use pseudomonas risk factors, sputum cultures and patterns of resistance)
Yes pseudomonas risk factors:
Levo 750 IV,
or
Piper-Taz 4.5g IV
or
2g Cefepime/ceftazidime
Obstructive sleep apnea definition
a common disorder that is characterized by obstructive apneas and hypopneas due to repetitive collapse of the upper airway during sleep
Obstructive sleep apnea Treatment
Weight loss exercise Changing sleep position Avoid alcohol Avoid certain meds CPAP
Acute Bronchitis Causes
Majority are caused by virus:
Rhinovirus
Coronavirus
Influenza virus
RSV
Bacterial cases are rare <10%
Most common are:
Chlamydia pneumoniae
Mycoplasma pneumoniae
Bordetella pertussis
Acute Bronchitis Tx
OTC
Dextromethorphan
Guaifenesin
Inhaled beta agonists are used for patients with wheezing and
underlying pulmonary disease
ABX are not recommended empirically
DXM MOA
Reduces the need to cough
inhibits the cough reflex
(dextromethorphan)
Low dose codeine MOA
Reduces the need to cough
inhibits the cough reflex
Guaifenesin MOA
Thins mucus making it easier to cough up
Expectorant
Reflex stimulation
Stimulates the respiratory tract secretions, allowing ciliary movement to carry the loosened secretions upward
Direct stimulation
The secretory glands are stimulated directly to increase their production of respiratory tract fluids
dextromethorphan
Delsym (OTC) (antitussive)
inhibits the cough reflex
Contra:
Don’t use under 4 years old
within 14 days of MAOI’s
Interactions:
Hyperpyretic crisis with MAOI’s
Guaifenesin
Mucinex (expectorant)
Thins mucus making it easier to cough up
Dose: Swallow whole, take with full glass of water, Q 12, max of 2 tabs per day
Adverse:
GI Upset, Drowsiness, HA, rash
Influenza tx
Anti-virals within 48 hours of onset of symptoms
Oseltamivir (neuraminidase inhibitor)
Oseltamivir
Tamiflu (neuraminidase inhibitor)
Acute uncomplicated illness within 48hours
>2 weeks of age
Prophylaxis of influenza >1 yr old
(not a substitute for Vaccine)
> 13 y/o 75mg BID x5 days
Interactions:
Not for use with live vaccine with 2 weeks prior or 48 hours after treatment
Empyema treatment
Infections in the pleural space that are community acquired
3rd gen Cef + metronidazole
or ampicillin-sulbactam (monotherapy)
Hospital acquired infections or post pneumonia
Vanc + metronidazole and anti-pseudomonal cef (cefepime, ceftazidime)
Cor Pulmonale
Treat underlying cause of Pulmonary disease
Prostanoids
For pulmonary HTN
relax and open arteries in the lungs by
targeting the prostacyclin pathway
These meds increase the prostacycin in the body
Oral, IV or inhaler
Endothelin receptor antagonist
For pulmonary HTN
Reverses the effects of endothelin
Endothelin causes blood vessel narrowing
this allows the blood vessels to open allowing more blood flow
PDE-5 inhibitors
For pulmonary HTN
Blocks the action of PDE-5
PDE-5 causes the smooth muscles in the lungs to constrict.
PDE-5 stops this allowing the vessels to open and more blood flow to the lungs
Soluble guanylate cyclase stimulator
For pulmonary HTN
A chemical in the body that interacts with Nitric Oxide
This drug stimulates sGC which then interacts with NO and increases blood flow through the vessels of the lungs
Anti-coagulants
For pulmonary HTN
Helps prevent blood clots from forming
can increase risk of bleeding and can interact with other drugs, herbals, and foods.
Diuretics
For pulmonary HTN
Eliminates excess H2O this helps Pulmonary HTN by reducing the water and the amount of work the heart has to do
Epoprostenol
Flovan (prostacyclin analogue)
Pulmonary arterial HTN (WHO group 1)
Contra
HF due to reduced left ventricle ejection fraction
Interactions
Hypotensive effects may be potentiated by diuretics, anti-hypertensives, vasodilators
increased risk of bleeding with anti-coagulants, anti-platelets
ambrisentan
Letairis (Endothelin receptor antagonist)
Pulmonary arterial HTN (WHO group 1)
Contra
Pregnancy, idiopathic pulmonary fibrosis including those with pulmonary HTN (WHO group 3)
Box warning
Fetal toxicity
riociguat
Adempas (Soluble guanylate cyclase stimulator)
Pulmonary arterial HTN (WHO group 1)
To improve exercise capacity
Contra
Pregnancy, Nitrates or NO, PDE-5 inhibitors, Pulmonary HTN associated with idiopathic interstitial pneumonia
Box warning
Fetal toxicity
PE treatment
Low risk of bleeding
High clinical suspicion
Low risk of bleeding
High clinical suspicion
Empiric anticoagulation until definitive tests are complete
PE treatment
hemodynamically unstable
with definitive diagnosis
Systemic thrombolytic therapy
rather than empiric anti coagulation
Which of the below meds is a short-acting anticholinergic med for COPD?
albuterol (Ventolin)
tiotropium (Spriva)
ipratropium (Atrovent)
salmeterol (Serevent)
ipratropium (Atrovent)
Which medication is considered a long-acting muscarinic antagonist?
albuterol (Ventolin)
tiotropium (Spriva)
ipratropium (Atrovent)
salmeterol (Serevent)
tiotropium (Spriva)
Which medication is considered a long-acting beta agonist?
albuterol (Ventolin)
tiotropium (Spriva)
ipratropium (Atrovent)
salmeterol (Serevent)
salmeterol (Serevent)
Which medication is considered a short-acting beta agonist?
albuterol (Ventolin)
tiotropium (Spriva)
ipratropium (Atrovent)
salmeterol (Serevent)
albuterol (Ventolin)
What category of cough medicines is best for the drug, dextromethorphan?
Analgesics
Antitussive
Antihistamine
Expectorant
Antitussive
Idiopathic Pulmonary Fibrosis Treatment
Supportive care
Select meds (pirfenidone, nintedanib)
participation in clinical trials
Referral for lung transplant
Treatment of Comorbidities
Idiopathic Pulmonary Fibrosis Treatment
Mild to moderate
pirfenidone, nintedanib
if available in the area
nintedanib
Ofev (kinase inhibitor)
Idiopathic Pulmonary Fibrosis
Adverse
NVD, abdominal pain, Liver enzyme elevation, decreased appetite
nintedanib active ingredient
Tyrosine Kinase inhibitor
inhibits growth factor
pirfenidone
Esbriet (pyridone)
Idiopathic Pulmonary Fibrosis
Antifibrotic, anti-inflammatory, anti-oxidant
Suppression of Tumor necrosis factor & interleukin
Warnings
Perform liver function tests prior to initiating treatment, monthly for the first 6 months, and every 3 months thereafter.
Permanently discontinue if ALT/AST >3 – ≤5XULN with symptoms or hyperbilirubinemia,
or if ALT/AST >5XULN occurs
Pneumoconiosis Treatment
Supplemental O2 (liquid or compressed)
Bronchodilators - to open lung passages
Not smoking - can exacerbate symptoms
Avoid harmful dust and particles
Sarcoidosis Definition
Sarcoidosis is a multisystem disease of unknown etiology characterized by tissue infiltration with noncaseating granulomas.
The granulomas may occur in any organ, but the most frequently affected sites are the lungs, lymph nodes, skin, eyes, and liver.
Sarcoidosis Treatment
Glucocorticoids
Attenuate the granulomatous inflammatory process
Sarcoidosis Treatment
Refractory to steroids
methotrexate(MTX) or azathioprine,
Prior to initiating therapy withmethotrexate(MTX),azathioprine, orleflunomide,
baseline complete blood counts and serum aminotransferases, albumin, and creatinine are obtained
Methotrexate
Rheumatrex (DMARD)
Folic acid antagonist
Contra
Alcoholism, Chronic liver disease, immnuodeficiency, blood dyscrasias, Preg Cat X, Nursing mothers
Warning
Severe toxic reactions, Deaths have been reported
Only used by experienced MD’s
Inform patients of risks
Adverse
Elevated liver enzymes, NV, Rash, Thrombocytopenia, stomatitis
Why use methotrexate for sarcoidosis
Methotrexate is one of the most commonly used corticosteroid-sparing therapies for sarcoidosis,
due to its effectiveness, low cost and, at the dosages used to treat sarcoidosis, relatively low risk of side effects compared to other cytotoxic agents.
Folic acid and methotrexate
Check CBC Liver and kidney labs ever 1-3 months
Folic acid supplements may be used to reduce toxicity
azathioprine
Imuran (immunosuppressant) (antimetabolite)
Contra
RA, Pregnancy, prior use of alkylating agents
Warning
Malignancy
Increased risk of lymphoma
Skin cancer
Adverse
Leukopenia, thrombocytopenia, anemia
azathioprine (Imuran)
Most common side effects
Diarrhea abdominal cramping hair loss Liver enzyme elevation Bone marrow suppression
Silicosis Treatment
Supportive Smoking cessation Bronchodilators Flu and Pneumo vaccine Supplemental O2
Systemic glucocorticoids have been used to interrupt the inflammation that leads to progressive silicosis
Preferred Antibiotic
Strep pneumo
Pen G
Amoxicillin
Preferred Antibiotic
Resistant strep pneumo
Ceftriaxone
Cefotaxime
Fluoroquinolones
Preferred Antibiotic
H FLu
Amoxicillin
Secondary 3rd gen Cef
or Augmentin
Preferred Antibiotic
Mycoplasma pneumonia
Macrolides
or tetracycline
Preferred Antibiotic
Chlamydophila pneumoniae
Macrolides
or tetracycline
Preferred Antibiotic
Legionella
Fluoroquinolones
or
Azithromycin
Preferred Antibiotic
Chlamydophila psittaci
Tetracycline
Preferred Antibiotic
Francisella tulaensis
Doxycycline
Preferred Antibiotic
Yesinia pestis
Streptomycin
or
gentamycin
Preferred Antibiotic
Coxiella burnetii
Tetracycline
Preferred Antibiotic
Bacillus anthracis
Cipro
Levo
Doxy
Preferred Antibiotic
Enterobacteriaceae
3rd gen Cef
Carbapenem
Preferred Antibiotic
Pseudomonas aeruginosa
antipseudomonal beta-lactam
Plus
Cipro or levo or aminoglycoside
Preferred Antibiotic
Burkholderia pseudomallei
Carbapenem
or
ceftazidime
Preferred Antibiotic
Acinetobacter
Carbapenem
Preferred Antibiotic
Staph aureus
Anti-staph penicillin
Preferred Antibiotic
MRSA
Vanc or linezolid
Preferred Antibiotic
Bordatella pertussis
Macrolide
Preferred Antibiotic
Anaerobes
Beta lactam inhibitor
or clindamycin
Preferred Antibiotic
Mycobacterium tuberculosis
RIPE (All 4)
Rifampin
Isoniazid
Pyrazinamide
Ethambutol
Preferred Antibiotic
coccidioides
No therapy if uncomplicated
if complicated
itraconazole
or
fluconazole
Preferred Antibiotic
Histoplasmosis
itraconazole
Preferred Antibiotic
Blastomycosis
itraconazole
Most common pulmonary disease in HIV patients
Pneumonia
Consequence of altered B cell function and/or defects in neutrophil function secondary to HIV
Most common bacteria in pneumoina of AIDS patients
Strep pneumo
and
H Flu
Pneumonias that occur with increased frequency in HIV patietns
Staph aureus
Pseudomonas aeruginosa
Pneumocystis Pneumonia (PCP) Treatment
Bactrim x 21 days
100% mortality if not treated
Bactrim prophylaxis in HIV patients
Bactrim prophylaxis for all HIV patients with a CD4 count of 200
Pneumocystis Pneumonia (PCP)
Medications for viral pneumonia
Anti virals
Fever reducers
Cough medicine
Asthma
intermittent
Step 1
SABA
Asthma
Mild persistent
Step 2
Low dose ICS
Asthma
Moderate persistent
Step 3
Low dose ICS
and
LABA
or Medium dose ICS
Asthma
Severe persistent
Step 4
Medium dose ICS
and
LABA
Asthma
Severe persistent
Step 5
High dose ICS
and
LABA
Asthma
Severe persistent
Step 6
High dose ICS
and
LABA
oral
corticosteroid
Short acting bronchodilators
Quick acting, rescue
lasts 2-4 hours
15-20 mins before exercise
Long acting bronchodilators
used to provide control
not quick relief
lasts for 12 hours
take 45 minutes to begin working
SABA
Most effective for quick relief
more than one canister a month is inadequate control
not for regular use
mat lower effectiveness
may increase airway hyperresponsiveness
Albuterol, levalbuterol
Terbutaline
Brethine (Beta 2 agonist)
Chronic Bronchitis, Asthma, Emphysema
Not for children
Warnings
not for preterm labor, avoid excess use, DM, Cardiac disease, Hypertension, hyperthyroidism, seizures, monitor potassium,
Preg Cat B
Adverse
Tachycardia, palpitaions, nervousness, tremors, HA, drowsiness, nausea
ICS Drugs
Beclamethasone Budesonide ciclesonide flunisolide fluticasone propionate DPI fluticasone furoate DPI Mometasone DPI Mometasone HFA
LABA Side effects
HA Pain Elevated BP Dizziness Nasal irritation Throat irritation
LABA Contraindications
Acute asthma attack
LABA precautions
CVD DM COPD Hyperthyroid Glaucoma Seizures Hypokalemia Pregnancy, lactation
Must be used with ICS
Pure LABAs
Salmeterol
Formeterol
Salmeterol
Serevent (LABA)
prevention and treatment of asthma
only used with ICS
Not for acute bronchospasm
Contra
Use without ICS, status asthmaticus, acute asthma, acute COPD
Warning
Asthma related death
LABA and ICS
FDA Approved
Advair
Fluticasone + Salmeterol
Airduo
Fluticasone + Salmeterol
Breo Ellipta
Fluticasone + vilanterol
Dulera
Mometasone + formoterol
Symbicort
Budesonide + Formoterol
Leukotriene receptor antagonist
Montelukast
zafirlukast
zileuton
LTRA
Leukotriene receptor antagonist
MOA
Montelukast
Zileuton
Anti-leukotriene agents inhibit the action of leukotrienes by blocking the CysLT1 receptor
Montelukast
Zafirlukast
Pranlukast
or
by interrupting production by 5-lipoxygenase
zileuton
LTRA
Leukotriene receptor antagonist
Anti-leukotriene agents inhibit the action of leukotrienes by blocking the CysLT1 receptor
What meds?
Montelukast
Zafirlukast
Pranlukast
MZP
Generally well tolerated
Be aware of possible psych , behavior, neurogenic issues
LTRA
Leukotriene receptor antagonist
by interrupting production by 5-lipoxygenase
Zileutron
Generally has more adverse effects than the others
montelukast
Singulair (leukotriene receptor antagonist)
Warning:
Serious neuropsychiatric events
Adverse:
URI, Fever, HA, Pharyngitis, cough, abdominal pain, diarrhea, otitis media, influenza, rhinorrhea, sinusitis
LTRA
Leukotriene receptor antagonist
MOA
Arachidonic acid
↓
↓ (5 -lipoxygenase) ≠ Zileuton (5-LO inhibitor)
↓
Leukotrienes
↓
↓ ≠ CysLT1 receptor antagonists
↓ ≠ Montelukast, pranlukast, zafirlukast
↓
Leukotrienes receptor
Zileuton
Zyflo (5-lipooxygenase inhibitor)
Prophylaxis and chronic treatment of asthma
Not recommended for Children
Contra:
Active liver disease, ALT elevated 3x normal limit
Warnings:
Not for primary treatment of acute attacks
Monitor liver function
History of liver disease, Monitor liver function 1st 3 months, every 2-3 months for remainder of the year
Alcohol consumption, neuropsych events
Interactions Potentiates theophylline (reduce dose of theophylline)
Mast Cell stabilizer
Cromolyn
Cromolyn
Intal (mast cell stabilizer)
Asthma prophylaxis
prevention of bronchoconstriction before exposure
Not for acute attack
Interactions
Pregnancy
Cromolyn MOA
Alters delayed chloride channels in cell membrane
inhibits cough
inhibits response to antigens (mast cells)
inhibits inflammation (eosinophils)
No smooth muscle effect
Only for prophylaxis of asthma
Methylxanthines
Theophylline
Theophylline
Theo-24 (Xanthine)
Asthma, Chronic bronchitis, Emphysema
Not for Acute attack
Adverse
GI upset, HA, CNS stimulations, Diuresis, arrhythmias, seizures
Theophylline MOA
Inhibits phosphodiesterase
anti-inflammatory and bronchodilator activity
through decreased mast cell mediator release
Immunomoduators
For patients whose asthma is inadequately controlled on high-dose inhaled glucocorticoids and LABAs, the anti-IgE therapyomalizumab(Xolair)may be considered if there is objective evidence of sensitivity to a perennial allergen (by allergy skin tests or in vitro measurements of allergen-specific IgE) and if the serum IgE level is within the established target range.
omalizumab
Xolair Anti-asthmatic (IgE blocker).
Moderate-to-severe persistent asthma in patients ≥6yrs of age with a (+) skin test orin vitroreactivity to a perennial aeroallergen and whose symptoms are inadequately controlled by inhaled corticosteroids.
Not for relief of acute bronchospasm or status asthmaticus. Not indicated for treatment of other allergic conditions.
Boxed Warning:
Anaphylaxis.
omalizumab
Neutralizes IgE in circulation
inhibits activation of IgE bound Mast cells
Down regulates IgE receptors on mast cells
The four important components of effective asthma therapy during pregnancy are:
Objective monitoring of maternal lung function and fetal well-being as a guide to therapy
Proper control of environmental and other triggers for asthma (eg, cigarette smoking, animal allergen exposure)
Patient education
Pharmacologic therapy
Acute asthma in pregnant patients
SABA (same as non preg)
Long term control for asthma in pregnant patients
Budesonide
beclomethasone
fluticasone
These are the preferred ICS’s
Elderly Asthma patients
Asthma is common over 65
Similar treatment to adults
No theophylline
mild persistent or more severe, we recommend using a controller regimen that includes inhaled glucocorticoids. Selection of the initial dose is based on symptom frequency and severity and degree of airflow obstruction.
Exercise induced asthma
Avoid triggers
SABA or
Combo (budesonide-formoterol) 160mcg/4.5mcg
1 puff, 5-20 mins prior to exercise
Alternatives include LTRA or ipratropium
Aspirin induced asthma
Cyclooxygenase pathway inhibition by ASA
results in shunting to second pathway of arachidonic acid metabolism
results in the production of leukotrienes
Status asthmaticus
ABX - (more needed with COPD)
Oxygen is a must
Mag sulfate
Mag sulfate
Single dose IV 2g over 20 minutes
(for severe exacerbation who are not responding to initial therapy)
IV mag has bronchodilator activity in acute asthma possibly due to inhibition of calcium influx into airway smooth muscle cells
TB
First Line
RIPE
Give all
Rifampin
Isoniazid
pyrazinamide
ethambutol
Rifampin MOA
and adverse
Blocks the beta subunit of bacterial RNA polymerase stopping bacterial RNA synthesis
Adverse
red/orange sweat/urine, induces p450, hepatitis
Isoniazid MOA
and adverse
Inhibits mycolic acid synthesis in cell wall
Adverse
Peripheral neuropathies, hepatitis, hepatotoxicity
pyrazinamide MOA
and adverse
Nicotinamide analog with unknown MOA
Adverse
hepatitis, hyperuricemia, gouty arthritis
(never used alone due to resistance)
ethambutol MOA
and adverse
Inhibits mycolic acid synthesis in cell wall
Adverse
reversible retrobulbar neuritis
loss of central vision
INH Interaction
Alcohol increases hepatitis
pyrazinamide contra
Sever hepatic damage
acute gout
Ethambutol Contra
Optic neuritis
Alpha 1 antitrypsin deficiency
Severe deficiency of alpha-1 antitrypsin (AAT)
due to certain genetic variants is associated with both early onset pulmonary emphysema
and several forms of liver disease, including cirrhosis, neonatal hepatitis, and hepatocellular carcinoma.
Alpha 1 antitrypsin deficiency
Lung transplant
Lung transplantation is reserved for patients with advanced emphysema due to severe AAT deficiency.
Similarly, liver transplantation is reserved for patients with end-stage hepatic disease.
After liver transplantation, the AAT deficiency is corrected, because the normal phenotype donor liver produces and secretes AAT.
Alpha 1 antitrypsin deficiency
For AAT deficient patients who are never or ex-smokers, age 18 or older with an AAT genetic variant consistent with severe AAT deficiency, and evidence of airflow limitation (forced expiratory volume in one second [FEV1] 30 to 65 percent predicted)…
Treatment
Intravenous augmentation with pooled human AAT.
MOA of Augmentation therapy
Augmentation therapy is intended to augment (add to) the amount of alpha-1 antitrypsin protein (AAT) floating in the blood and bathing the tissues of the body in people with lung disease related to Alpha-1.
Alpha 1 proteinase inhibitor
Prolastin C
Adverse
URI, UTI, Nausea, pain, chills, cough, dizziness, dyspnea, HA, Hot flush, oral candidiasis
ARDS treatment
Key components of supportive care include appropriate use of sedatives, careful hemodynamic management (Oxygen supplementation via prone positioning and fluid management), nutritional support, control of blood glucose, expeditious evaluation and treatment of nosocomial pneumonia, and prophylaxis against deep vein thrombosis (DVT) and gastrointestinal (GI) bleeding.
Omalizumab
Not for relief of acute bronchospasm or status asthmaticus. Not indicated for treatment of other allergic conditions.
Boxed Warning:
Anaphylaxis.
Antiasthmatic (IgE blocker).
Immunomodulators
For patients whose asthma is inadequately controlled on high-dose inhaled glucocorticoids and LABAs, the anti-IgE therapyomalizumab(Xolair)may be considered if there is objective evidence of sensitivity to a perennial allergen (by allergy skin tests or in vitro measurements of allergen-specific IgE) and if the serum IgE level is within the established target range.
What is the most common pneumonia associated with patients having HIV-related illnesses?
Pneumocystis
Streptococcal
Legionella
Mycoplasma
Streptococcal
What is the most common therapy for patients with Pneumocystis pneumonia?
azithromycin
clarithromycin
TMP-SMX
vancomycin
TMP-SMX
Which of the below is the most accurate asthma classification for patients that have to use a SABA more than twice a week but not daily?
Intermittent
Mild persistent
Moderate persistent
Severe persistent
Mild persistent
Which of the following is the correct Step therapy for a patient with moderate persistent asthma classification?
Step 2
Step 3
Step 4
Step 5
Step 3
Which of the following medication is considered a mast cell stabilizer?
Cromolyn (Intal)
Zileuton (Zyflo)
Theophylline (Theo-24)
Omalizumab (Xolair)
Cromolyn (Intal)
What Vitamin B should be given with INH?
Vitamin B1
Vitamin B3
Vitamin B6
Vitamin B12
Vitamin B6
Which antiarrhythmic is known to cause drug-induced pulmonary fibrosis?
Quinidine
Amiodarone
Propafenone
Adenosine
Amiodarone